Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

The Effect of Lactobacillus gasseri BNR17 on Postmenopausal Symptoms in Ovariectomized Rats

  • Received : 2021.05.24
  • Accepted : 2021.07.16
  • Published : 2021.09.28
Download PDF
⟨ Previous Next ⟩

Abstract

Clinical and preclinical studies have reported that Lactobacillus gasseri BNR17, a probiotic bacterial strain isolated from human breast milk, reduces body weight and white adipose tissue volume. In order to further explore the actions of L. gasseri BNR17, we investigated the anti-menopausal effects of L. gasseri BNR17 in an ovariectomized (OVX) rat model. The serum alanine aminotransferase levels of the rats in the OVX-BNR17 group were lower than those of the rats in the OVX-vehicle only (OVX-Veh) group. Upon administration of L. gasseri BNR17 after ovariectomy, calcitonin and Serotonin 2A levels increased significantly, whereas serum osteocalcin levels showed a decreasing tendency. Compared to the rats in the OVX-Veh group, those in the OVX-BNR17 group showed lower urine deoxypyridinoline levels, lower pain sensitivity, and improved vaginal cornification. Furthermore, L. gasseri BNR17 administration increased bone mineral density in the rats with OVX-induced femoral bone loss. These results suggest that L. gasseri BNR17 administration could alleviate menopausal symptoms, indicating that this bacterium could be a good functional probiotic for managing the health of older women.

Keywords

References

  1. Davis SR, Lambrinoudaki I, Lumsden M, Mishra GD, Pal L, Rees M, et al. 2015. Menopause. Nat. Rev. Dis. Primers 1: 15004. https://doi.org/10.1038/nrdp.2015.4
  2. Monteleone P, Mascagni G, Giannini A, Genazzani AR, Simoncini T. 2018. Symptoms of menopause - global prevalence, physiology and implications. Nat. Rev. Endocrinol. 14: 199-215. https://doi.org/10.1038/nrendo.2017.180
  3. Mohammadalizadeh Charandabi S, Rezaei N, Hakimi S, Montazeri A, Taheri S, Taghinejad H, et al. 2015. Quality of life of postmenopausal women and their spouses: a community-based study. Iran Red. Crescent. Med. J. 17: e21599. https://doi.org/10.5812/ircmj.21599
  4. Hill K. 1996. The demography of menopause. Maturitas 23: 113-127. https://doi.org/10.1016/0378-5122(95)00968-X
  5. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333. https://doi.org/10.1001/jama.288.3.321
  6. Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, et al. 2013. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 310: 1353-1368. https://doi.org/10.1001/jama.2013.278040
  7. Steinkellner AR, Denison SE, Eldridge SL, Lenzi LL, Chen W, Bowlin SJ. 2012. A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women's Health Initiative. Menopause 19: 616-621. https://doi.org/10.1097/gme.0b013e31824bb039
  8. Moyer VA, Force USPST. 2013. Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 158: 47-54. https://doi.org/10.7326/0003-4819-158-1-201301010-00553
  9. Lim EY, Lee SY, Shin HS, Lee J, Nam YD, Lee DO, et al. 2020. The effect of Lactobacillus acidophilus YT1 (MENOLACTO) on improving menopausal symptoms: a randomized, double-blinded, placebo-controlled clinical trial. J. Clin. Med. 9: 2173. https://doi.org/10.3390/jcm9072173
  10. Rao RK, Samak G. 2013. Protection and restitution of gut barrier by probiotics: nutritional and clinical implications. Curr. Nutr. Food Sci. 9: 99-107. https://doi.org/10.2174/1573401311309020004
  11. Dimidi E, Christodoulides S, Scott SM, Whelan K. 2017. Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Adv. Nutr. 8: 484-494. https://doi.org/10.3945/an.116.014407
  12. Brusaferro A, Cozzali R, Orabona C, Biscarini A, Farinelli E, Cavalli E, et al. 2018. Is it time to use probiotics to prevent or treat obesity? Nutrients 10: 1613. https://doi.org/10.3390/nu10111613
  13. Wallace CJK, Milev R. 2017. The effects of probiotics on depressive symptoms in humans: a systematic review. Ann. Gen. Psychiatry 16: 14. https://doi.org/10.1186/s12991-017-0138-2
  14. Collins FL, Rios-Arce ND, Schepper JD, Parameswaran N, McCabe LR. 2017. The potential of probiotics as a therapy for osteoporosis. Microbiol. Spectr. 5: 10.1128/microbiolspec.BAD-0015-2016.
  15. Zhang J, Lu Y, Wang Y, Ren X, Han J. 2018. The impact of the intestinal microbiome on bone health. Intractable Rare Dis. Res. 7: 148-155. https://doi.org/10.5582/irdr.2018.01055
  16. Takada M, Nishida K, Gondo Y, Kikuchi-Hayakawa H, Ishikawa H, Suda K, et al. 2017. Beneficial effects of Lactobacillus casei strain Shirota on academic stress-induced sleep disturbance in healthy adults: a double-blind, randomised, placebo-controlled trial. Benef. Microbes 8: 153-162. https://doi.org/10.3920/BM2016.0150
  17. Karakula-Juchnowicz H, Rog J, Juchnowicz D, Loniewski I, Skonieczna-Zydecka K, Krukow P, et al. 2019. The study evaluating the effect of probiotic supplementation on the mental status, inflammation, and intestinal barrier in major depressive disorder patients using gluten-free or gluten-containing diet (SANGUT study): a 12-week, randomized, double-blind, and placebo-controlled clinical study protocol. Nutr. J. 18: 50. https://doi.org/10.1186/s12937-019-0475-x
  18. Shin SP, Choi YM, Kim WH, Hong SP, Park JM, Kim J, et al. 2018. A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome. J. Clin. Biochem. Nutr. 62: 179-186. https://doi.org/10.3164/jcbn.17-73
  19. Kim J, Yun JM, Kim MK, Kwon O, Cho B. 2018. Lactobacillus gasseri BNR17 supplementation reduces the visceral fat accumulation and waist circumference in obese adults: A randomized, double-blind, placebo-controlled trial. J. Med. Food 21: 454-461. https://doi.org/10.1089/jmf.2017.3937
  20. Jung SP, Lee KM, Kang JH, Yun SI, Park HO, Moon Y, et al. 2013. Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: a randomized, double-blind clinical trial. Korean J. Fam Med. 34: 80-89. https://doi.org/10.4082/kjfm.2013.34.2.80
  21. Yun SI, Park HO, Kang JH. 2009. Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J. Appl. Microbiol. 107: 1681-1686. https://doi.org/10.1111/j.1365-2672.2009.04350.x
  22. Abdallah HM, Al-Abd AM, Asaad GF, Abdel-Naim AB, El-halawany AM. 2014. Isolation of antiosteoporotic compounds from seeds of Sophora japonica. PLoS One 9: e98559. https://doi.org/10.1371/journal.pone.0098559
  23. Shim JG, Yeom SH, Kim HJ, Choi YW, Lee DI, Song KY, et al. 2005. Bone loss preventing effect of sophorae fructus on ovariectomized rats. Arch Pharm. Res. 28: 106-110. https://doi.org/10.1007/BF02975144
  24. Kang JH, Yun SI, Park MH, Park JH, Jeong SY, Park HO. 2013. Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PLoS One 8: e54617. https://doi.org/10.1371/journal.pone.0054617
  25. Parhizkar S, Latiff LA. 2013. Supplementary health benefits of linoleic acid by improvement of vaginal cornification of ovariectomized rats. Adv. Pharm. Bull. 3: 31-36.
  26. Li LH, Wang ZC, Yu J, Zhang YQ. 2014. Ovariectomy results in variable changes in nociception, mood and depression in adult female rats. PLoS One 9: e94312. https://doi.org/10.1371/journal.pone.0094312
  27. Liao CC, Chiu YS, Chiu WC, Tung YT, Chuang HL, Wu JH, et al. 2015. Proteomics analysis to identify and characterize the molecular signatures of hepatic steatosis in ovariectomized rats as a model of postmenopausal status. Nutrients 7: 8752-8766. https://doi.org/10.3390/nu7105434
  28. Dalal PK, Agarwal M. 2015. Postmenopausal syndrome. Indian J. Psychiatry 57: S222-232. https://doi.org/10.4103/0019-5545.161483
  29. Clayton AH, Ninan PT. 2010. Depression or menopause? Presentation and management of major depressive disorder in perimenopausal and postmenopausal women. Prim Care Companion J. Clin. Psychiatry 12: PCC 08r00747.
  30. Shaif NA, Chang DH, Cho D, Kim S, Seo DB, Shim I. 2018. The Antidepressant-like effect of lactate in an animal model of menopausal depression. Biomedicines 6: 108. https://doi.org/10.3390/biomedicines6040108
  31. Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD. 1991. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J. Clin. Endocrinol. Metab. 72: 367-373. https://doi.org/10.1210/jcem-72-2-367
  32. Zoch ML, Clemens TL, Riddle RC. 2016. New insights into the biology of osteocalcin. Bone 82: 42-49. https://doi.org/10.1016/j.bone.2015.05.046
  33. Forsberg JG. 1995. A morphologist's approach to the vagina--age-related changes and estrogen sensitivity. Maturitas 22 Suppl: S7-S15. https://doi.org/10.1016/0378-5122(95)00957-4
  34. Shibata K, Takeda M, Ito A, Takeda M, Sagai H. 1998. Ovariectomy-induced hyperalgesia and antinociceptive effect of elcatonin, a synthetic eel calcitonin. Pharmacol. Biochem. Behav. 60: 371-376. https://doi.org/10.1016/S0091-3057(98)00015-X
  35. Ito A, Takeda M, Furue H, Shibata K, Hori M, Sagai H, et al. 2004. Administration of estrogen shortly after ovariectomy mimics the anti-nociceptive action and change in 5-HT1A-like receptor expression induced by calcitonin in ovariectomized rats. Bone 35: 697-703. https://doi.org/10.1016/j.bone.2004.04.012
  36. Tanaka T, Takao-Kawabata R, Takakura A, Shimazu Y, Nakatsugawa M, Ito A, et al. 2020. Teriparatide relieves ovariectomy-induced hyperalgesia in rats, suggesting the involvement of functional regulation in primary sensory neurons by PTH-mediated signaling. Sci. Rep. 10: 5346. https://doi.org/10.1038/s41598-020-62045-4
  37. Bahar H, Gallacher K, Downall J, Nelson CA, Shomali M, Hattersley G. 2016. Six weeks of daily abaloparatide treatment increased vertebral and femoral bone mineral density, microarchitecture and strength in ovariectomized osteopenic rats. Calcif. Tissue Int. 99: 489-499. https://doi.org/10.1007/s00223-016-0171-1
  38. Khosla S, Riggs BL. 2005. Pathophysiology of age-related bone loss and osteoporosis. Endocrinol. Metab. Clin. North Am. 34: 1015-1030, xi. https://doi.org/10.1016/j.ecl.2005.07.009
  39. Lei Z, Xiaoying Z, Xingguo L. 2009. Ovariectomy-associated changes in bone mineral density and bone marrow haematopoiesis in rats. Int. J. Exp. Pathol. 90: 512-519. https://doi.org/10.1111/j.1365-2613.2009.00661.x
  40. 2001. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. South Med. J. 94: 569-573. https://doi.org/10.1097/00007611-200194060-00004
  41. Turner AS. 2001. Animal models of osteoporosis--necessity and limitations. Eur. Cell Mater. 1: 66-81. https://doi.org/10.22203/eCM.v001a08
  42. Li CL, Liu XL, Cai WX, Lu WW, Zwahlen RA, Zheng LW. 2014. Effect of ovariectomy on stimulating intracortical remodeling in rats. Biomed. Res. Int. 2014: 421431.
  43. Cao H, Zhang Y, Qian W, Guo XP, Sun C, Zhang L, et al. 2017. Effect of icariin on fracture healing in an ovariectomized rat model of osteoporosis. Exp. Ther. Med. 13: 2399-2404. https://doi.org/10.3892/etm.2017.4233
  44. Hernandez CJ, Guss JD, Luna M, Goldring SR. 2016. Links between the microbiome and bone. J. Bone Miner. Res. 31: 1638-1646. https://doi.org/10.1002/jbmr.2887
  45. Villa ML, Marcus R, Ramirez Delay R, Kelsey JL. 1995. Factors contributing to skeletal health of postmenopausal Mexican-American women. J. Bone Miner. Res. 10: 1233-1242. https://doi.org/10.1002/jbmr.5650100814
  46. Dardmeh F, Nielsen HI, Alipour H, Kjaergaard B, Brandsborg E, Gazerani P. 2016. Potential nociceptive regulatory effect of probiotic Lactobacillus rhamnosus PB01 (DSM 14870) on mechanical sensitivity in diet-induced obesity model. Pain Res. Manag. 2016: 5080438.
  47. Zabel M. 1985. Studies on in vitro effect of serotonin on calcitonin secretion by rat thyroid C cells. Histochemistry 83: 71-75. https://doi.org/10.1007/BF00495303
  48. Pun KK, Chan LW. 1989. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. Clin. Ther. 11: 205-209.
  49. Pontiroli AE, Pajetta E, Calderara A, Alberetto M, Pozza G, Manganelli V, et al. 1991. Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bones: a pilot study. J. Endocrinol. Invest. 14: 47-51. https://doi.org/10.1007/BF03350260
  50. Maricic MJ. 2012. Oral calcitonin. Curr. Osteoporos. Rep. 10: 80-85. https://doi.org/10.1007/s11914-011-0084-x
  51. Azria M, Copp DH, Zanelli JM. 1995. 25 years of salmon calcitonin: from synthesis to therapeutic use. Calcif. Tissue Int. 57: 405-408. https://doi.org/10.1007/BF00301940
  52. Abbiati G, Arrigoni M, Frignani S, Longoni A, Bartucci F, Castiglioni C. 1994. Effect of salmon calcitonin on deoxypyridinoline (Dpyr) urinary excretion in healthy volunteers. Calcif. Tissue Int. 55: 346-348. https://doi.org/10.1007/BF00299312
  53. Akcay MN, Akcay G, Yilmaz I. 2002. The effect of calcitonin and growth hormone on urinary deoxypyridinoline levels in burned patients. Burns. 28: 311-313. https://doi.org/10.1016/S0305-4179(02)00013-X
  54. Malaivijitnond S, Chansri K, Kijkuokul P, Urasopon N, Cherdshewasart W. 2006. Using vaginal cytology to assess the estrogenic activity of phytoestrogen-rich herb. J. Ethnopharmacol. 107: 354-360. https://doi.org/10.1016/j.jep.2006.03.026
  55. Gray LE, Jr., Wilson V, Noriega N, Lambright C, Furr J, Stoker TE, et al. 2004. Use of the laboratory rat as a model in endocrine disruptor screening and testing. ILAR J. 45: 425-437. https://doi.org/10.1093/ilar.45.4.425
  56. Pendharkar S, Magopane T, Larsson PG, de Bruyn G, Gray GE, Hammarstrom L, et al. 2013. Identification and characterisation of vaginal Lactobacilli from South African women. BMC Infect. Dis. 13: 43. https://doi.org/10.1186/1471-2334-13-43
  57. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. 2011. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA 108 Suppl 1: 4680-4687. https://doi.org/10.1073/pnas.1002611107
  58. Lara-Villoslada F, Olivares M, Sierra S, Rodriguez JM, Boza J, Xaus J. 2007. Beneficial effects of probiotic bacteria isolated from breast milk. Br. J. Nutr. 98 Suppl 1: S96-100. https://doi.org/10.1017/S0007114507832910
  59. Lubiech K, Twaruzek M. 2020. Lactobacillus bacteria in breast milk. Nutrients 12: 3783. https://doi.org/10.3390/nu12123783
  60. Marcotte H, Krogh Andersen K, Lin Y, Zuo F, Zeng Z, Larsson PG, et al. 2017. Characterization and complete genome sequences of L. rhamnosus DSM 14870 and L. gasseri DSM 14869 contained in the EcoVag((R)) probiotic vaginal capsules. Microbiol. Res. 205: 88-98. https://doi.org/10.1016/j.micres.2017.08.003
  61. Parolin C, Marangoni A, Laghi L, Foschi C, Nahui Palomino RA, Calonghi N, et al. 2015. Isolation of vaginal Lactobacilli and characterization of anti-candida activity. PLoS One 10: e0131220. https://doi.org/10.1371/journal.pone.0131220
  62. Martin R, Sanchez B, Suarez JE, Urdaci MC. 2012. Characterization of the adherence properties of human Lactobacilli strains to be used as vaginal probiotics. FEMS Microbiol. Lett. 328: 166-173. https://doi.org/10.1111/j.1574-6968.2011.02495.x
  63. Anderson DJ, Marathe J, Pudney J. 2014. The structure of the human vaginal stratum corneum and its role in immune defense. Am. J. Reprod. Immunol. 71: 618-623. https://doi.org/10.1111/aji.12230
  64. Joo SS, Kwon SH, Hwang KW, Lee DI. 2005. Improvement of menopausal signs by isoflavones derived from Sophorae fructus in ovariectomized female rats and the antioxidant potentials in BV2 cells. Arch. Pharm. Res. 28: 566-572. https://doi.org/10.1007/BF02977760
  65. Elberry A, Mufti S, Al-Maghrabi J, Ghareib S, Mosli H, El-Halawany A, et al. 2020. The protective effect of Sophora japonica on prostatic hypertrophy and inflammation in rat. Inflammopharmacology 28: 1525-1536. https://doi.org/10.1007/s10787-020-00723-5
  66. Lee J, Kim KW, Kim HK, Chae SW, Jung JC, Kwon SH, et al. 2010. The effect of Rexflavone (Sophorae fructus extract) on menopausal symptoms in postmenopausal women: a randomized double-blind placebo controlled clinical trial. Arch. Pharm. Res. 33: 523-530. https://doi.org/10.1007/s12272-010-0405-0